|
PTHS Pelthos Therapeutics Inc 1919246 |
| Balance Sheet |
|
Current Assets
|
$63,356,000.00 |
|
Assets
|
$137,356,000.00 |
|
Current Liabilities
|
$31,959,000.00 |
|
Liabilities
|
$138,857,000.00 |
|
Equity
|
$-1,501,000.00 |
|
Shares Out
|
3718624.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-20,790,000.00 |
|
Investing Cash Flow
|
$-196,000.00 |
| Market Analysis |
Market Cap
|
$99,138,515.84 |
|
Price
|
$26.66 |
|
BVPS
|
10.42 |
|
PB
|
2.56 |
|
EPS
|
-6.62 |
|
PS
|
1.59 |
|
FCF
|
$-20,986,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:51 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:41 |
|
| Apr |
May |
Jun |
| 2026-03-19 |
-6.87 |
|
|
2026-05-14 |
-3.09 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PTHS documents filed with the SEC.
PTHS Filings
Clear
